Fungal fingerprints in lungs may predict ABPA Flare-Ups
NCT ID NCT07690345
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study looks at people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a common fungus. Researchers want to see if having fungus detectable in sputum or lung fluid samples is linked to more frequent flare-ups or worse outcomes. Participants will be followed for 12 months to track exacerbations and changes in immune markers and lung function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If fungal status predicts outcomes, doctors could tailor treatments more precisely for ABPA patients.
- What could go wrong
- This is an observational study, not a treatment trial. It may not prove cause and effect, and results might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABPA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
RECRUITINGJinan, Shandong, 250014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI model aims to predict dangerous lung Flare-Ups in ABPA patients
- Superbug sleuths decode the DNA of drug-resistant e. coli to stop its spread
- AI model aims to predict ABPA relapse risk
- New drug could tame severe asthma and fungal allergy
- Steroid combo may improve tough lung fungus treatment
- Can a Pea-Coated probiotic boost your gut bugs?